KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) Other Non Operating Income (2017 - 2021)

Elevance Health (ELV) has disclosed Other Non Operating Income for 8 consecutive years, with -$16.0 million as the latest value for Q4 2021.

  • Quarterly Other Non Operating Income fell 700.0% to -$16.0 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$16.0 million through Dec 2022, up 23.81% year-over-year, with the annual reading at -$21.0 million for FY2021, 41.67% up from the prior year.
  • Other Non Operating Income for Q4 2021 was -$16.0 million at Elevance Health, down from -$5.0 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $6.0 million in Q4 2018, with the low at -$282.0 million in Q4 2017.
  • Average Other Non Operating Income over 5 years is -$27.0 million, with a median of -$3.0 million recorded in 2019.
  • The sharpest move saw Other Non Operating Income skyrocketed 105.56% in 2019, then tumbled 700.0% in 2021.
  • Over 5 years, Other Non Operating Income stood at -$282.0 million in 2017, then soared by 102.13% to $6.0 million in 2018, then crashed by 150.0% to -$3.0 million in 2019, then surged by 33.33% to -$2.0 million in 2020, then crashed by 700.0% to -$16.0 million in 2021.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$16.0 million, -$5.0 million, and -$2.0 million for Q4 2021, Q2 2021, and Q4 2020 respectively.